Electra Therapeutics, Inc. Common stock (ETRA)

Electra Therapeutics, Inc. Common stock (ETRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $549M; returns 1 day -5.8%, 1 week -0.5%.

Electra Therapeutics, Inc. (NASDAQ: ETRA) is a clinical-stage biotechnology company focused on targeting signal regulatory proteins (SIRP) to develop novel therapies for severe immunological diseases and oncology. The company's platform targets SIRP receptors across myeloid and T cell populations to deplete hyperactive or pathological immune cells without causing generalized immunosuppression.

Groups ETRA belongs to

• Recent IPOs
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Antibody Therapeutics
• Monoclonal Antibodies
• Rare Diseases
• Immunotherapy
• Oncology
• Cancer Therapeutics
• Autoimmune Diseases
• Chronic Inflammatory Diseases

ETRA financial model: income statement, cash flow and balance sheet